A carregar cotações...
Previsão
Não temos dados de analistas para esta empresa.
Discussões na comunidade
Ainda não há nenhuma discussão sobre este ativo.
Iniciar discussãoNotícias Ir para o feed de notícias
Redwood AI stock falls as much as 20% after record high
Redwood AI stock plunged in Toronto by as much as 20% after earlier reaching a record high of CAD 10.10. The pullback points to massive profit-taking and a technical correction following heavy speculation, but the month-to-date performance remains around +45%. Operationally the picture stays positive: British Columbia is funding a pilot project with CAD 300,000, the AI platform Reactosphere received an important update, and there is a collaboration with the University of British Columbia. As a young company after its IPO in February 2026, the stock reacts very volatile to news. » Mais em finanzen.net
Redwood AI expands Reactosphere with global price and availability monitoring
Redwood AI announces an update to its AI-based chemical synthesis platform Reactosphere that monitors prices and availability from more than 90 global suppliers and can integrate internal customer prices and inventories. The expansion is intended to help procurement teams identify alternative suppliers faster, reduce supply bottlenecks and optimize decisions taking tariffs and logistics factors into account. The project is partially supported by consulting services and up to $75,000 in funding from NRC IRAP to develop a scalable price data infrastructure, and is targeted particularly at pharmaceutical companies, CDMOs, research institutions and defense applications. » Mais em finanzen.net
Redwood AI launches research collaboration with Brent Page Lab at UBC on Alzheimer’s drug development
Redwood AI and the Brent Page Lab at the University of British Columbia have launched a joint research project to develop novel therapeutics against Alzheimer’s, focused on inhibitors of the protein NUDT5. Redwood will provide an AI-powered computing platform to design and evaluate synthetically accessible drug analogs, accelerating the selection of promising candidates and proposing prioritized molecules for synthesis and experimental testing. The Page Lab will perform the experimental validation, aiming to identify promising preclinical candidates more quickly. » Mais em finanzen.net
Redwood AI starts Mitacs-funded project with UBC and QAI to accelerate synthesis using quantum-AI
Redwood AI will launch in April 2026 a Mitacs Accelerate–funded research project in collaboration with the University of British Columbia and the Quantum Algorithms Institute to combine AI and quantum computing for chemical synthesis. The aim is to improve predictions across molecular spaces and make synthesis routes more efficient and cost-effective through quantum-assisted optimization. Redwood will gain access to quantum infrastructure, including D-Wave platforms, and will provide a Mitacs postdoctoral researcher to work on the project. » Mais em finanzen.net
Redwood AI presents AI platform Reactosphere at BIO‑Europe Spring 2026
Redwood AI was selected to give a company presentation at BIO‑Europe Spring 2026 in Lisbon. CEO Louis Dron will present the AI-powered platform Reactosphere on March 25, which offers automated evaluation and comparison of synthesis routes while taking operational constraints such as material availability, safety and supply‑chain reliability into account. The platform aims to improve early development decisions and to support applications in pharmaceutical research, manufacturing and in security and defense sectors. » Mais em finanzen.net